Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Quest Diagnostics Lowers FY2025 GAAP EPS Guidance from $8.60-$8.80 to $8.58-$8.66 vs $8.68 Est

Author: Benzinga Newsdesk | October 21, 2025 05:47am
Quest Diagnostics (NYSE:DGX) lowers FY2025 GAAP EPS guidance from $8.60-$8.80 to $8.58-$8.66 vs $8.68 analyst estimate..

Posted In: DGX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist